Progressively consider new data to improve our impact on patient health
Our ambition is to advance research and contribute to the development of new, innovative and effective cancer therapies. To help better understand and treat cancer, we are progressively considering new structured health data within our Health Data Warehouse.
- Improving patients' quality of life, adherence to treatment and overall survival.
- Offering users more personalized, more appropriate, more human support.
- In France, remote cancer monitoring solutions have been able to access the market through the integration of telemonitoring into public services.
- For this solution to be reimbursed, we must demonstrate to the French Health Authority (HAS) that it has continued clinical and organizational benefits, through clinical studies and real-world data.
- Furthering scientific discoveries and driving new standards based on ePRO (Patient Reported Outcome) questionnaires
- Precise understanding of each patient thanks to clinical, biological and behavioral data
Proving our impact and contributing to medical research
We want to evaluate our solution through clinical trials, and scientifically demonstrate its benefits on patient quality of life and treatment adherence. We work with cancer research institutes, healthcare institutions and scientists for this purpose.
Evaluation of the impact of a telemonitoring system for patients undergoing first-line treatment for diffuse large B-cell lymphoma. large B-cell lymphoma
Describe the events that occur during and after R-CHOP treatment, and assess the impact of using Resilience Pro to detect and manage these events.
- Hôpital privé du Confluent
- Jean Bernard Center
- Robertsau Radiotherapy Center
- Polyclinique Bordeaux Nord Aquitaine
- Hospital Center
- Polyclinique Bordeaux Nord Aquitaine
- Cesson Sévigné Hospital
Dr Katell Le Dû
Hematologist
Hopital Privé du Confluent - Nantes
Optimizing the surgical care pathway for kidney tumors by digitizing perioperative nursing coordination
To evaluate the effectiveness of digitizing perioperative nursing coordination on the use of unscheduled care (RSNP) during the month following nephrectomy for kidney tumor.
Bordeaux University Hospital
Caen University Hospital
CHU Rennes
Strasbourg University Hospital
Toulouse University Hospital
APHP Henri Mondor
CHU Angers
APHM Conception Hospital
Medipole Cabestany
CH Mont de Marsan
CHU Nîmes
Prof. Jean-Christophe BERNHARD
Department of Urological Surgery and Renal Transplantation
CHU BORDEAUX
Odyssea personalized approach: randomized Phase II study to determine the effectiveness of a personalized approach in improving quality of life in patients receiving adjuvant hormone therapy for early-stage breast cancer.
The main objective of OPERA is to determine the effectiveness of a personalized approach, consisting of a multi-component, multi-level interventional application (first module), compared with standard care, in improving quality of life (QOL) after 12 weeks.
Gustave Roussy Institute
Léon Bérard Centre
Center Georges François Leclerc
Center François Baclesse
Dr. Inês VAZ-LUIS
Breast cancer treatment service
Gustave Roussy
Assessing the clinical and organizational impact of remote patient monitoring during cancer treatment
To study the impact of the Resilience RPM system on clinical outcomes, healthcare resource utilization, costs and the experience of patients diagnosed with cancer and receiving active treatment.
> 15 centers
Dr. Inês VAZ-LUIS
Breast cancer treatment service
Gustave Roussy
STEpwise research program to promote INGeniouS online support solutions for the relief of cancer-related fatigue
The main objective of SteppingSTONE is to compare the effectiveness of three different modalities of digital assistance (educational material; educational material plus self-management program - self-administered; educational material plus self-management program - therapist-guided) in reducing the perceived burden of CRF.
Gustave Roussy
Bordeaux University Hospital
Institut Bergonié
Dr Ines VAZ-LUIS
Gustave Roussy
Groupe de Recherche sur la Survie du Cancer du Sein (Breast Cancer Survival Research Group)
INSERM Unit 981
Digital telemonitoring and usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
The aim of this study (Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics; CAPRI) was to evaluate an intervention combining nurse navigator monitoring and a mobile app for patients receiving oral anticancer agents in addition to usual care, designed to simultaneously pursue three dimensions: improving the patient experience of care; improving the health of the target population; and reducing the per capita cost of healthcare.
Olivier Mir, Marie Ferrua, Aude Fourcade, Delphine Mathivon, Adeline Duflot-Boukobza, Sarah Dumont, Eric Baudin, Suzette Delaloge, David Malka, Laurence Albiges, Patricia Pautier, Caroline Robert, David Planchard, Stéphane de Botton, Florian Scotté, François Lemare, May Abbas, Marilène Guillet, Vanessa Puglisi, Mario Di Palma & Etienne Minvielle
Setting up a PROACTive care pathway to empower and support breast cancer survivors
Optimal and comprehensive survivorship care, beyond screening for recurrence and new cancers, and including health promotion, management of physical and psychosocial needs and chronic disease, is not sufficiently delivered. To increase patient empowerment and maximize the adoption of multidisciplinary strategies addressing all survivor needs, we have implemented a proactive survivorship care pathway offered to early breast cancer patients at the end of their primary treatment phase (surgery, chemotherapy, radiotherapy).
Maria Alice Franzoi, Lena Degousée, Elise Martin, Patricia Miguel Semedo, Marion Aupomerol, Davide Soldato, Antonio Di Meglio, Camila Chiodi, Aude Barbier, Hajer Chaouachi, Nathalie Renvoisé, Diane Boinon, Léonor Fasse, Joana Ribeiro, Jean Bernard Le-Provost, Johanna Arvis, Céline Lazorthes, Mario di Palma, Anne de Jesus, Bruno Raynard, Arnaud Pagès, Suzette Delaloge, Barbara Pistilli, Florian Scotté, and Ines Vaz-Luis
Digital transformation of perioperative protocols coordinated by the renal surgery nurse for improved recovery and ambulatory surgery using the UroConnect® application.
Robotic-assisted partial nephrectomy (RAPN) is a standard of care for localized renal tumors. It provides good carcinological control while limiting complications. Despite its many advantages, the economic viability of robotic assistance remains a challenge in the French healthcare system. With the aim of improving the efficiency of nursing care within these protocols, we have set up digitalized nurse coordination by developing a urological perioperative application: UroConnect®. This device is offered to patients by nurse coordinators during a preoperative visit.
G.Margue, E.Callede, S.Ricard, F.Picard, C.Dubernet, G.Robert, F.Bladou, J.C.Bernhard.
The Resilience Health Data Warehouse
Resilience was authorized to set up its Health Data Warehouse by CNIL deliberation no. 2022-049 on April 21, 2022. Intended to be used for research, studies or evaluations in the healthcare field, this database enables us to meet three major challenges:
Thanks to the anonymized data collected from our partner establishments, we are constantly improving our solution. To meet the needs of caregivers, we regularly develop new functionalities to predict side effects and relapses.
Real-life data collected from our users will enable us to evaluate and study the impact of our remote monitoring solution on the organization of care and its adoption by patients and caregivers.
- Offering a single pathway and providing the right care at the right time.
- A precise understanding of each patient thanks to the clinical, biological and behavioral data collected.
Elodie, Fanny, Arlindo, Maximilien, Carlota: they are oncologists, psychiatrists, pharmacists or researchers. They work every day to study and understand the impact of Resilience on patients and caregivers.
Are you a healthcare professional and want to know more about Resilience? Contact us!